Literature DB >> 25767335

Oral hybrid verrucous carcinoma: a clinical study.

Sandhya Gokavarapu1, L M Chandrasekhara Rao S1, Uma Sankar Tantravahi1, Sandhya Devi Gundimeda1, T Subramaneshwar Rao1, Sudha Murthy1.   

Abstract

Hybrid Verrucous Carcinoma is an uncommon tumour wherein Verrucous Carcinoma (VC) is coexisting with conventional Squamous Cell Carcinoma (SCC) within same maternal field. The heterogeneous nature, infrequency of occurrence and the difficulties associated with diagnosis and management of this tumor is discussed through a retrospective study. Patients of primary hybrid VC treated from Jan 2010 to May 2013 at a tertiary institute were analyzed on multivariate cox regression model. During the above mentioned period; 37 patients of hybrid VC were reported; 18(48.6 %) were male and 19(51.3 %) were female. Age ranged between 33 years to 78 years. Median follow up period was 32 months. T stage status and Stage grouping was not statistically significant for mortality (p value: 0.338). In the multivariate cox-regression model, the presence of second primary oral cancer was significantly associated with mortality, adjusted HR; 23.10 (95 % CI: 1.73, 307.65) (p = 0.017). Tumour staging is often unreliable in predicting prognosis of hybrid VC, occurrence of second primary oral cancer and recurrence appears to be significant factors effecting prognosis.

Entities:  

Keywords:  Hybrid verrucous carcinoma; Oral cancer; Verrucous carcinoma

Year:  2014        PMID: 25767335      PMCID: PMC4354831          DOI: 10.1007/s13193-014-0345-0

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  24 in total

1.  Multiple head and neck tumors: evidence for a common clonal origin.

Authors:  G C Bedi; W H Westra; E Gabrielson; W Koch; D Sidransky
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

Review 2.  Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis.

Authors:  Julia Anne Woolgar; Asterios Triantafyllou
Journal:  Oral Oncol       Date:  2008-10-11       Impact factor: 5.337

3.  Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue?

Authors:  R M Byers; A K El-Naggar; Y Y Lee; B Rao; B Fornage; N H Terry; D Sample; P Hankins; T L Smith; P J Wolf
Journal:  Head Neck       Date:  1998-03       Impact factor: 3.147

Review 4.  The pathology of head and neck tumors: verrucous carcinoma, Part 15.

Authors:  J G Batsakis; R Hybels; J D Crissman; D H Rice
Journal:  Head Neck Surg       Date:  1982 Sep-Oct

5.  Synchronous and metachronous tumours in patients with head and neck cancer.

Authors:  G J Hordijk; J M de Jong
Journal:  J Laryngol Otol       Date:  1983-07       Impact factor: 1.469

Review 6.  Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience.

Authors:  J S Cooper; T F Pajak; P Rubin; L Tupchong; L W Brady; S A Leibel; G E Laramore; V A Marcial; L W Davis; J D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-09       Impact factor: 7.038

7.  p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx.

Authors:  V A Ball; P D Righi; E Tejada; S Radpour; Z P Pavelic; J L Gluckman
Journal:  Ear Nose Throat J       Date:  1997-11       Impact factor: 1.697

8.  Verrucous-squamous carcinomas of the oral cavity. A clinicopathologic study of 104 cases.

Authors:  J E Medina; W Dichtel; M A Luna
Journal:  Arch Otolaryngol       Date:  1984-07

Review 9.  Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.

Authors:  Jonessa Ann S Atienza; Constantin A Dasanu
Journal:  Curr Med Res Opin       Date:  2012-11-23       Impact factor: 2.580

10.  Second head and neck cancers following radiation therapy of T1 and T2 cancers of the oral cavity and oropharynx.

Authors:  J Fijuth; J J Mazeron; C Le Péchoux; P Piedbois; M Martin; E Haddad; E Calitchi; B Pierquin; J P Le Bourgeois
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.